Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient’s blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.
Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott’s ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes.
Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period.
Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing.
Geographically, the global hemoglobin A1c testing devices market is categorized into four regions, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the market leader in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of automated processes is rapid in this region which results in high demand for advanced laboratory and point-of-care testing devices with new technologies. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR than others, owing to the presence of unmet healthcare needs, large diabetic population and increase in healthcare expenditure. Moreover, rising diabetes awareness among the general population will generate demand for diagnostic devices for HbA1c testing. Also, inadequate accessibility to the clinical laboratories in this region, demands more of point-of-care devices to enable immediate results during the patient visit.
The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis.
Determining the levels of glycated hemoglobin gives assurance to healthcare practitioners about decision making on the treatment to be prescribed to diabetic patients. Such tests are primarily used for diagnosis and monitoring of hemoglobin A1c levels. Hemoglobin A1c test provides the average amount of patient’s glucose levels in last 2 to 3 months, therefore, it is preferred over other conventionally used blood glucose tests. Due to this reason, medical practitioners are increasingly recommending hemoglobin A1c testing devices over glucose testing devices to diabetic patients which has lead to increased use of hemoglobin A1c testing devices.
This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers, research organizations involved in developing new and innovative technologies for hemoglobin A1c testing devices and the new players who wish to enter this market. The report consists of executive summary, which provides the market snapshot containing the information of segments of hemoglobin A1c testing devices market. This section also includes the comparative analysis of hemoglobin A1c market based on different geographical regions.
The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that have an influence on the current and future scenario of this market. This section also covers market attractiveness analysis and Porter’s five forces analysis to give an understanding about the competitive scenario of the global hemoglobin A1C testing devices market. Heat map Analysis is also provided for hemoglobin A1c testing devices market to explain the presence of the different market players in diverse market segments. All these factors will help the market players and new entrants in planning their strategies for future and for strengthening their position in the global market.
The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses of hemoglobin A1c testing devices. With respect to technologies, this study considers five testing categories, namely immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. The above segments are analyzed on the basis of their market size (revenue) for the period 2011 to 2019 in terms of USD million, along with their growth forecast in terms of compounded annual growth rate (CAGR) % for the forecast period 2013 to 2019, considering 2012 as the base year.
With respect to geographical markets, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market for hemoglobin A1C testing devices market in terms of USD million. The section also includes the CAGR % for every region for the given forecast period, considering 2012 as the base year.
The report further provides a list of strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market. This report concludes with the company profiles section that includes key information such as company overview, financial overview, product portfolio, strategies and recent developments about major market players. Some of the major companies profiled in this report include Abbott Laboratories, Alere, Inc., Arkray, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc. Chek Diagnostics, Danaher Corporation, EKF Diagnostics Holdings Plc, Menarini Group, F. Hoffmann-La Roche Ltd., Sebia, Tosoh Corporation, Trinity Biotech Plc and Siemens Healthcare.
The global hemoglobin A1c testing devices market is categorized into the following segments:
Hemoglobin A1cTesting Devices Market, by End-use
- Laboratory Testing Devices
- Point-of-Care (POC)Testing Devices
Hemoglobin A1cTesting Devices Market, by Technology
- Ion-Exchange High Performance Liquid Chromatography (HPLC)
- Boronate Affinity Chromatography
- Direct Enzymatic Assay
- Others (Micro-Optical Detection Method and Capillary Electrophoresis)
Hemoglobin A1cTesting Devices Market, by Geography
- North America
- Rest of the World (RoW)